8 things to know about drug-resistant tuberculosis

by Sandeep Juneja, Senior Vice President, Market Access, TB Alliance

Price reduction paves the way for expanded access to highly effective multidrug-resistant tuberculosis treatment

by MedAccess, Viatris and TB Alliance

BASF and MedAccess complete shipment of 35 million Interceptor® G2 nets to fight malaria

by BASF and MedAccess

Five key lessons from our first five years

by MedAccess

Professor Helen Rees appointed MedAccess Board Chair

by MedAccess

MedAccess expects to deploy more than $150 million to support Global Fund’s fight against HIV, TB and malaria

by MedAccess

P. vivax malaria elimination efforts boosted by new agreement to expand access to G6PD testing

by MedAccess

The reality of undiagnosed syphilis for mothers and babies

by Laura Mundy, External Relations Associate

Partners announce reduced price for patient-friendly tuberculosis preventive treatments

by MedAccess, Unitaid, CHAI and The Aurum Institute

5 things you should know about HIV self-testing

by Clinton Health Access Initiative (CHAI)

AVAC, BMGF, CIFF, MedAccess, Unitaid, and ViiV Healthcare announce collaboration to catalyse more affordable access to long-acting injectable cabotegravir for HIV prevention

by MedAccess and partners

New agreement secures historic US$1 price for HIV self-test

by MedAccess, CHAI and Wondfo

2021 Annual Review: Accelerating impact and preparing for the future

by MedAccess

Global COVID-19 Summit: MedAccess’ commitment to vaccine access

by MedAccess

New partnership to help meet country demand for COVID-19 vaccines

by MedAccess, Gavi, OSF

MedAccess and BASF welcome positive trial results for next-generation mosquito net

by MedAccess

MedAccess welcomes inclusion of COVID-19 assay in Hologic’s Global Access Initiative

by MedAccess

Violet Mordichai joins MedAccess on board apprenticeship programme

by MedAccess

8 things to know about drug-resistant tuberculosis

Price reduction paves the way for expanded access to highly effective multidrug-resistant tuberculosis treatment

BASF and MedAccess complete shipment of 35 million Interceptor® G2 nets to fight malaria

Five key lessons from our first five years

Professor Helen Rees appointed MedAccess Board Chair

MedAccess expects to deploy more than $150 million to support Global Fund’s fight against HIV, TB and malaria

P. vivax malaria elimination efforts boosted by new agreement to expand access to G6PD testing

The reality of undiagnosed syphilis for mothers and babies

Partners announce reduced price for patient-friendly tuberculosis preventive treatments

5 things you should know about HIV self-testing

AVAC, BMGF, CIFF, MedAccess, Unitaid, and ViiV Healthcare announce collaboration to catalyse more affordable access to long-acting injectable cabotegravir for HIV prevention

New agreement secures historic US$1 price for HIV self-test

2021 Annual Review: Accelerating impact and preparing for the future

Global COVID-19 Summit: MedAccess’ commitment to vaccine access

New partnership to help meet country demand for COVID-19 vaccines

MedAccess and BASF welcome positive trial results for next-generation mosquito net

MedAccess welcomes inclusion of COVID-19 assay in Hologic’s Global Access Initiative

Violet Mordichai joins MedAccess on board apprenticeship programme

Our partners

Subscribe to our newsletter